Drugs such as dipeptidyl‐peptidase IV (DPP‐IV) inhibitors, which inhibit the degradation of GLP‐1, are widely used for treatment of type 2 diabetes mellitus (type 2 DM).14 This evidence concerns the gene GLP1R and type 2 diabetes mellitus.